Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy (Q45738503)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2001

Language	Label	Description	Also known as
English	Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy	scientific article published in January 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Fukutomi T

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Nakamuta M

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Fukutomi M

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Iwao M

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Watanabe H

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hiroshige K

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Tanabe Y

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Nawata H

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

100-107

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis C viremia following interferon-alpha administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C transmission between spouses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic analysis of hepatitis C virus in American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900044-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(00)00044-1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45738503&oldid=2079858271"